Literature DB >> 6449518

Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia.

L S Levine, B Dupont, F Lorenzen, S Pang, M Pollack, S Oberfield, B Kohn, A Lerner, E Cacciari, F Mantero, A Cassio, C Scaroni, G Chiumello, G F Rondanini, L Gargantini, G Giovannelli, R Virdis, E Bartolotta, C Migliori, C Pintor, L Tato, F Barboni, M I New.   

Abstract

Serum androgens and 17-hydroxyprogesterone concentrations and HLA genotypes were determined in 124 families of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH). In 8 pedigrees, we discovered 16 pubertal or postpubertal family members of either sex who had biochemical evidence of 21-hydroxylase deficiency but were without clinical symptoms of excess virilism, amenorrhea, or infertility. We designated these family members as individuals with cryptic 21-hydroxylase deficiency. Within each generation, the family members with cryptic 21-hydroxylase deficiency were HLA identical. It is proposed that these family members are genetic compounds, having 21-hydroxylase deficiency as a result of two recessive gene defects: 1) a severe 21-hydroxylase gene defect present in the index case with classical CAH (21-OHCAH) and 2) a mild 21-hydroxylase gene defect (21-OHCRYPTIC). Thus, the CAH genotype in the family members with cryptic 21-hydroxylase deficiency is 21-OHCAH/21-OHCRYPTIC. Lod score analysis for linkage between the cryptogenic 21-OH trait and HLA gave a combined Lod score for males and females of theta = 0.00 of 3.409. Close genetic linkage between HLA and 21-OHCRYPTIC was thus established. This study provides support for the previously reported heterogeneity of 21-hydroxylase deficiency which may result from allelic variability at the locus for steroid 21-hydroxylase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6449518     DOI: 10.1210/jcem-51-6-1316

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Non-classic adrenal hyperplasia in hyperandrogenism: a reappraisal.

Authors:  C Morán; E S Knochenhauer; R Azziz
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

2.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

3.  Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families.

Authors:  Radha Nandagopal; Ninet Sinaii; Nilo A Avila; Carol Van Ryzin; Wuyan Chen; Gabriela P Finkielstain; Sneha P Mehta; Nazli B McDonnell; Deborah P Merke
Journal:  Eur J Endocrinol       Date:  2011-03-28       Impact factor: 6.664

4.  Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis.

Authors:  A Boué; F Muller; C Nezelof; J F Oury; F Duchatel; Y Dumez; M C Aubry; J Boué
Journal:  Hum Genet       Date:  1986-11       Impact factor: 4.132

5.  Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.

Authors:  M I New; R C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  HLA genotypes and HLA-linked genetic markers in Italian patients with classical 21-hydroxylase deficiency.

Authors:  M S Pollack; M I New; G J O'Neill; L S Levine; C Callaway; S Pang; E Cacciari; F Mantero; A Cassio; C Scaroni; G Chiumello; G F Rondanini; L Gargantini; G Giovannelli; R Virdis; E Bartolotta; C Migliori; C Pintor; L Tato; F Barboni; B Dupont
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

Review 7.  21-Hydroxylase deficiency: from molecular genetics to clinical presentation.

Authors:  E Trakakis; D Laggas; E Salamalekis; G Creatsas
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

8.  New reliable biochemical marker for screening 21 alpha-hydroxylase deficiency without index person among hirsute women in agreement with HLA-haplotyping.

Authors:  A Chryssikopoulos; I Phocas; A Sarandakou; E Trakakis; D Rizos
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

9.  Congenital adrenal hyperplasia due to combined 21- and 11 beta-hydroxylase deficiency.

Authors:  R Penny; P Vecsei
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

10.  Altered CYP21 genes in HLA-haplotypes associated with congenital adrenal hyperplasia (CAH): a family study.

Authors:  B J Manfras; M Swinyard; W A Rudert; E J Ball; P A Lee; P Kühnl; M Trucco; B O Böhm
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.